PEAK6 Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,092
Closed -$948K 4463
2018
Q1
$899K Buy
+4,092
New +$961K ﹤0.01% 2061
2017
Q4
Sell
-9,074
Closed -$1.93M 4263
2017
Q3
$1.72M Sell
9,074
-5,768
-39% -$1.1M 0.01% 1510
2017
Q2
$2.79M Buy
+14,842
New +$2.67M 0.02% 1081
2017
Q1
Sell
-16,933
Closed -$2.69M 4450
2016
Q4
$2.43M Buy
+16,933
New +$2.27M 0.02% 1161
2015
Q4
Sell
-40,315
Closed -$5.55M 4882
2015
Q3
$5.64M Buy
+40,315
New +$6.06M 0.03% 800
2015
Q1
Sell
-13,774
Closed -$1.96M 4855
2014
Q4
$1.73M Sell
13,774
-6,049
-31% -$747K 0.01% 1452
2014
Q3
$2.37M Buy
19,823
+10,183
+106% +$1.17M 0.02% 1113
2014
Q2
$1.04M Sell
9,640
-28,079
-74% -$2.89M 0.01% 1604
2014
Q1
$3.75M Buy
37,719
+6,152
+19% +$556K 0.03% 818
2013
Q4
$2.92M Buy
31,567
+6,493
+26% +$577K 0.02% 1130
2013
Q3
$1.05M Buy
+25,074
New +$2.15M 0.01% 2117

Other funds holding ELV

PEAK6 Group's ELV Position: Q2 2018 in Review

PEAK6 Group sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 4,092 shares — an estimated $948K sold.

PEAK6 Group first reported a position in ELV in Q3 2013 and held it in 11 quarters. The position peaked at $5.64M in Q3 2015. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

  • PEAK6 Group reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 4,092 Elevance Health shares in Q2 2018, an estimated $948K.
  • PEAK6 Group first reported a position in Elevance Health in Q3 2013 and held it in 11 quarters.
  • PEAK6 Group's Elevance Health position peaked at $5.64M in Q3 2015.
  • 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.